What 4 Analyst Ratings Have To Say About HOOKIPA Pharma
Portfolio Pulse from Benzinga Insights
Four analysts have provided ratings for HOOKIPA Pharma (NASDAQ:HOOK) within the last quarter, with three bullish and one indifferent. The average price target is $5.56, representing an upside from the current price of $1.13. The current average represents a 14.46% decrease from the previous average price target of $6.50.
June 05, 2023 | 1:02 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
HOOKIPA Pharma (NASDAQ:HOOK) has received 3 bullish and 1 indifferent ratings from analysts, with an average price target of $5.56, indicating potential upside.
The majority of analysts have a bullish outlook on HOOKIPA Pharma, with an average price target of $5.56, which is significantly higher than the current price of $1.13. This indicates a potential upside for the stock in the short term, as the analysts' ratings are based on their research and expertise in the sector.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100